Search results for: 'biosensor analysis market'

Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provide...

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...

Comprehensive wound assessment is vital to understand the nature of wounds and devise evidence-based and cost-effective therapeutic interventions. However, traditionally used methods for wound diagnosis and monitoring cannot accurately measure wound dimensions, require physical contact with the wound, which causes discomfort to the patients, and ca...

The conventional drug discovery and diagnostics technologies are unable to cope up with the current disease management practices. To this end, researchers have explored possibilities beyond life sciences. Specifically, they have figured out that the use of engineering principles to biological systems can revolutionize the drug discovery and diagnos...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

The global medical imaging equipment and informatics industry is experiencing increasing demand for primary care, high prevalence of chronic diseases, and high footfall in screening centers, which are driving its growth. 2023 marked an increasing focus on oncology and precision imaging, indicated by the rising procurement of computed tomography (CT...

This research consists of an analysis of developments in biosensors

Technology Convergence Driving High Performance Diagnostics The healthcare industry is evidencing a significant paradigm shift with the advent of smart technologies associated with other fields of research that are remarkably empowering advanced diagnostics. When looking through innovations in the fields of nanotechnology, robotics, and three-dimen...

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...